In the presence of a factor VIII inhibitor, the Bethesda titer should be determined in the management of a patient with __________ when therapy involves Factor VIII concentrates.

Question

Quizplus · Accepted Answer

In the presence of a factor VIII inhibitor, the Bethesda titer should be determined in the management of a patient with Hemophilia when therapy involves Factor VIII concentrates. The Bethesda titer is used to quantify the amount of factor VIII inhibitor in a patient's plasma, and can help monitor the effectiveness of treatment. This is important in the management of hemophilia, as factor VIII concentrates are typically used to treat bleeding episodes, but if the patient has developed an inhibitor, the treatment may not be effective.

In the Presence of a Factor VIII Inhibitor, the Bethesda